PCMT1 and urinary bladder carcinoma: To sum up, this study showed that LINC00511 was significantly overexpressed in bladder cancer, and silencing LINC00511 could reduce the proliferation and invasion ability of bladder cancer cells, and its molecular mechanism might be to inhibit the expression of miR-143-3p and promote the expression of PCMT1.